These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38357767)
1. Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis. Seo HM; Oh SU; Kim S; Park JH; Kim JS J Eur Acad Dermatol Venereol; 2024 Aug; 38(8):1514-1521. PubMed ID: 38357767 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. Pindado-Ortega C; Saceda-Corralo D; Moreno-Arrones ÓM; Rodrigues-Barata AR; Hermosa-Gelbard Á; Jaén-Olasolo P; Vañó-Galván S J Am Acad Dermatol; 2021 May; 84(5):1285-1294. PubMed ID: 33038469 [TBL] [Abstract][Full Text] [Related]
3. Oral dutasteride is a first-line treatment for frontal fibrosing alopecia. Vano-Galvan S; Saceda-Corralo D J Eur Acad Dermatol Venereol; 2024 Aug; 38(8):1455-1456. PubMed ID: 39049754 [No Abstract] [Full Text] [Related]
4. Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. Ladizinski B; Bazakas A; Selim MA; Olsen EA J Am Acad Dermatol; 2013 May; 68(5):749-55. PubMed ID: 23375454 [TBL] [Abstract][Full Text] [Related]
7. 5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update. Murad A; Bergfeld W J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1385-1390. PubMed ID: 29524253 [TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M; J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187 [TBL] [Abstract][Full Text] [Related]
9. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Lee S; Lee YB; Choe SJ; Lee WS Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Zhou Z; Song S; Gao Z; Wu J; Ma J; Cui Y Clin Interv Aging; 2019; 14():399-406. PubMed ID: 30863034 [TBL] [Abstract][Full Text] [Related]
11. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. Rácz E; Gho C; Moorman PW; Noordhoek Hegt V; Neumann HA J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1461-70. PubMed ID: 23531029 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study. Vañó-Galván S; Saceda-Corralo D; Moreno-Arrones OM; Rodrigues-Barata R; Morales C; Gil-Redondo R; Bernárdez-Guerra C; Hermosa-Gelbard Á; Jaén-Olasolo P Dermatol Ther; 2020 Jan; 33(1):e13182. PubMed ID: 31820540 [TBL] [Abstract][Full Text] [Related]
13. Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation. Cranwell WC; Sinclair R Australas J Dermatol; 2017 Aug; 58(3):e94-e96. PubMed ID: 27273740 [TBL] [Abstract][Full Text] [Related]
14. Dutasteride in Androgenetic Alopecia: An Update. Arif T; Dorjay K; Adil M; Sami M Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070 [TBL] [Abstract][Full Text] [Related]
15. Medical therapy for frontal fibrosing alopecia: A review and clinical approach. Ho A; Shapiro J J Am Acad Dermatol; 2019 Aug; 81(2):568-580. PubMed ID: 30953702 [TBL] [Abstract][Full Text] [Related]
16. Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up. Banka N; Mubki T; Bunagan MJ; McElwee K; Shapiro J Int J Dermatol; 2014 Nov; 53(11):1324-30. PubMed ID: 24738979 [TBL] [Abstract][Full Text] [Related]
17. Hyperpigmentation following Treatment of Frontal Fibrosing Alopecia. Pérez-Rodríguez IM; García-Melendez ME; Eichelmann K; Vázquez-Martínez O; Ocampo-Candiani J Case Rep Dermatol; 2013; 5(3):357-62. PubMed ID: 24348386 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. Gupta AK; Charrette A J Dermatolog Treat; 2014 Apr; 25(2):156-61. PubMed ID: 23768246 [TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. Choi S; Kwon SH; Sim WY; Lew BL J Dermatol; 2024 May; 51(5):684-690. PubMed ID: 38321615 [TBL] [Abstract][Full Text] [Related]
20. Frontal fibrosing alopecia in Asians: a retrospective clinical study. Suchonwanit P; Pakornphadungsit K; Leerunyakul K; Khunkhet S; Sriphojanart T; Rojhirunsakool S Int J Dermatol; 2020 Feb; 59(2):184-190. PubMed ID: 31605393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]